Fluvastatin, a lipophilic statin, induces apoptosis in human hepatocellular carcinoma cells through mitochondria-operated pathway

Indian Journal of Experimental Biology

Volumn 48, Issue 12, 2010, Pages 1167-1174

  Zhang, Wu ^a,b   Wu, Jian ^a,b   Zhou, Lin ^a,b   Xie, Hai Yang ^a,b   Zheng, Shu Sen ^a,b  

^a ZHEJIANG UNIVERSITY   (China)

^b ZHEJIANG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

Fluvastatin; Hepatocellular carcinoma; Mitochondria operated pathway

Indexed keywords

CASPASE 3; CYTOCHROME C; FLUINDOSTATIN; HYPOCHOLESTEROLEMIC AGENT; INDOLE DERIVATIVE; MONOUNSATURATED FATTY ACID;

APOPTOSIS; ARTICLE; CELL ADHESION; CELL CYCLE; CELL MOTION; CELL PROLIFERATION; DRUG EFFECT; HUMAN; LIVER CELL CARCINOMA; LIVER TUMOR; METABOLISM; MITOCHONDRIAL MEMBRANE POTENTIAL; MITOCHONDRION; PATHOLOGY; TUMOR CELL CULTURE; WESTERN BLOTTING;

ANTICHOLESTEREMIC AGENTS; APOPTOSIS; BLOTTING, WESTERN; CARCINOMA, HEPATOCELLULAR; CASPASE 3; CELL ADHESION; CELL CYCLE; CELL MOVEMENT; CELL PROLIFERATION; CYTOCHROMES C; FATTY ACIDS, MONOUNSATURATED; HUMANS; INDOLES; LIVER NEOPLASMS; MEMBRANE POTENTIAL, MITOCHONDRIAL; MITOCHONDRIA; TUMOR CELLS, CULTURED;

EID: 78649423169     PISSN: 00195189     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Parkin D M, Bray F, Ferlay J & Pisani P, Global cancer statistics, 2002, CA Cancer J Clin, 55 (2005) 74.
2. Thomas M B & Zhu A X, Hepatocellular carcinoma: The need for progress, J Clin Oncol, 23 (2005) 2892.
3. Llovet J M & Beaugrand M, Hepatocellular carcinoma: Present status and future prospects, J Hepatol, 38 Suppl 1 (2003) S136.
4. Goldstein J L & Brown M S, Regulation of the mevalonate pathway, Nature, 343 (1990) 425.
5. Mrowka P, Glodkowska E, Nowis D, Legat M, Issat T, Makowski M, Szokalska A, Janowska S, Stoklosa T, Jakobisiak M & Golab J, Ciglitazone, an agonist of peroxisome proliferator-activated receptor gamma, exerts potentiated cytostatic/cytotoxic effects against tumor cells when combined with lovastatin, Int J Oncol, 32 (2008) 249.
6. Mistafa O & Stenius U, Statins inhibit Akt/PKB signaling via P2X7 receptor in pancreatic cancer cells, Biochem Pharmacol, 78 (2009) 1115.
7. Zhong W B, Liang Y C, Wang C Y, Chang T C & Lee W S, Lovastatin suppresses invasiveness of anaplastic thyroid cancer cells by inhibiting Rho geranylgeranylation and RhoA/ROCK signaling, Endocr Relat Cancer, 12 (2005) 615.
8. Woodard J, Sassano A, Hay N & Platanias L C, Statindependent suppression of the Akt/mammalian target of rapamycin signaling cascade and programmed cell death 4 up-regulation in renal cell carcinoma, Clin Cancer Res, 14 (2008) 4640.
9. Lewis K A, Holstein S A & Hohl R J, Lovastatin alters the isoprenoid biosynthetic pathway in acute myelogenous leukemia cells in vivo, Leuk Res, 29 (2005) 527.
10. Kawata S, Yamasaki E, Nagase T, Inui Y, Ito N, Matsuda Y, Inada M, Tamura S, Noda S, Imai Y & Matsuzawa Y, Effect of pravastatin on survival in patients with advanced hepatocellular carcinoma. A randomized controlled trial, Br J Cancer, 84 (2001) 886.
11. Knox J J, Siu L L, Chen E, Dimitroulakos J, Kamel-Reid S, Moore M J, Chin S, Irish J, LaFramboise S & Oza A M, A Phase I trial of prolonged administration of lovastatin in patients with recurrent or metastatic squamous cell carcinoma of the head and neck or of the cervix, Eur J Cancer, 41 (2005) 523.
12. Alsheikh-Ali A A, Maddukuri P V, Han H & Karas R H, Effect of the magnitude of lipid lowering on risk of elevated liver enzymes, rhabdomyolysis, and cancer: Insights from large randomized statin trials, J Am Coll Cardiol, 50 (2007) 409.
13. Poynter J N, Gruber S B, Higgins P D, Almog R, Bonner J D, Rennert H S, Low M, Greenson J K & Rennert G, Statins and the risk of colorectal cancer, N Engl J Med, 352 (2005) 2184.
14. Farwell W R, Scranton R E, Lawler E V, Lew R A, Brophy M T, Fiore L D & Gaziano J M, The association between statins and cancer incidence in a veterans population, J Natl Cancer Inst, 100 (2008) 134.
15. Vinot S, Anguille C, de Toledo M, Gadea G & Roux P, Analysis of cell migration and its regulation by Rho GTPases and p53 in a three-dimensional environment, Methods Enzymol, 439 (2008) 413.
16. Minichsdorfer C & Hohenegger M, Autocrine amplification loop in statin-induced apoptosis of human melanoma cells, Br J Pharmacol, 157 (2009) 1278.
17. Herrero-Martin G & Lopez-Rivas A, Statins activate a mitochondria-operated pathway of apoptosis in breast tumor cells by a mechanism regulated by ErbB2 and dependent on the prenylation of proteins, FEBS Lett, 582 (2008) 2589.
18. Sekine Y, Furuya Y, Nishii M, Koike H, Matsui H & Suzuki K, Simvastatin inhibits the proliferation of human prostate cancer PC-3 cells via down-regulation of the insulin-like growth factor 1 receptor, Biochem Biophys Res Commun, 372 (2008) 356.
19. Wong W W, Dimitroulakos J, Minden M D & Penn L Z, HMG-CoA reductase inhibitors and the malignant cell: The statin family of drugs as triggers of tumor-specific apoptosis, Leukemia, 16 (2002) 508.
20. Wu J, Wong W W, Khosravi F, Minden M D & Penn L Z, Blocking the Raf/MEK/ERK pathway sensitizes acute myelogenous leukemia cells to lovastatin-induced apoptosis, Cancer Res, 64 (2004) 6461.
21. Hentosh P, Yuh S H, Elson C E & Peffley D M, Sterolindependent regulation of 3-hydroxy-3-methylglutaryl coenzyme A reductase in tumor cells, Mol Carcinog, 32 (2001) 154.
22. Green D R & Kroemer G, The pathophysiology of mitochondrial cell death, Science, 305 (2004) 626.
23. Susin S A, Lorenzo H K, Zamzami N, Marzo I, Snow B E, Brothers G M, Mangion J, Jacotot E, Costantini P, Loeffler M, Larochette N, Goodlett D R, Aebersold R, Siderovski D P, Penninger J M & Kroemer G, Molecular characterization of mitochondrial apoptosis-inducing factor, Nature, 397 (1999) 441.
24. Wang W, Yang L & Huang H W, Evidence of cholesterol accumulated in high curvature regions: Implication to the curvature elastic energy for lipid mixtures, Biophys J, 92 (2007) 2819.
25. Siperstein M D, Cholesterol, cholesterogenesis and cancer, Adv Exp Med Biol, 369 (1995) 155.
26. Montero J, Morales A, Llacuna L, Lluis J M, Terrones O, Basanez G, Antonsson B, Prieto J, Garcia-Ruiz C, Colell A & Fernandez-Checa J C, Mitochondrial cholesterol contributes to chemotherapy resistance in hepatocellular carcinoma, Cancer Res, 68 (2008) 5246.
27. Salvesen G S & Dixit V M, Caspase activation: The inducedproximity model, Proc Natl Acad Sci U S A, 96 (1999) 10964.